The landscape of pharmacogenomic interactions in human cancer
收藏官方服务：
资源简介：
The landscape of pharmacogenomic interactions in human cancer
应用场景：
创建时间：
2016-07-05
相关数据集
Gene expression data from HepG2 SND1 knockdown stable cell lines after 5-Fu treatment. Gene expression data from HepG2 SND1 knockdown stable cell lines after 5-Fu treatment
SND1 protein is a highly conserved protein of eukaryotic cells and is involved in a group of cellular biological processes, such as gene transcription, pre-mRNA splicing, cell cycle, DNA damage repair
NIAID Data Ecosystem50
DataSheet1_Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients.pdf
Tamoxifen (TAM), a selective oestrogen receptor modulator, is one of the most used treatments in oestrogen receptor-positive (ER+) early and metastatic breast cancer (BC) patients. The response to TAM
NIAID Data Ecosystem30
Table S3 from Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures
Supplementary Table 3 binarization sensitivity 19 drugs
Figshare2023-08-10 更新20
Additional file 14 of Machine learning approach informs biology of cancer drug response
Additional file 14. Supplementary Table S12. Top 20 GO Biological Processes enrichment of elastic-net derived genes for PTX analysis without blood cancers. P-values shown are uncorrected for multiple
Figshare2022-05-17 更新40
Fluvastatin-induced differential global gene expression in human metastatic MDA-MB-231 breast cancer cells
The current study analyzed the altered expression profiles of genes that are responsible for fluvastatin-induced breast cancer cell death in MDA-MB-231 cells (ER-ve basal breast cancer cells). Some of
NIAID Data Ecosystem30
